bg
A

Arbutus Biopharma (ABUS)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Arbutus Biopharma (ABUS)

Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing cure for people with chronic hepatitis B virus (HBV) infection. Its product pipeline is focused on find... Read more

  • USD2.93
  • USD3.01
  • USD2.89
  • USD3.29
  • 7.20%
  • 18M
  • 746.17k
  • 628.63k
  • 544M
  • 1.69
  • 18.30%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.